J. Chmielecki

Pulmonary and Respiratory Medicine · 2010–2017

A researcher in the Science corpus: 7 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Chmielecki trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. William Pao
  2. L. Tanoue

Papers from J. Chmielecki's perspective

Ordered by how strongly the researchers J. Chmielecki trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  2. Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors (Clinical Cancer Research)
  3. Mutations of the BRAF gene in human cancer (Nature)
  4. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib (PLoS Medicine)
  5. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M (Nature)
  6. RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF (Nature)
  7. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer (Nature)
  8. ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors (Nature Reviews. Cancer)
  9. Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants (PLoS Medicine)
  10. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP (Proceedings of the National Academy of Sciences of the United States of America)

Their papers